Structure of 188111-79-7
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Discovery of Inhibitory Fragments That Selectively Target Spire2-FMN2 Interaction
Kitel, Radoslaw ; Surmiak, Ewa ; Borggrafe, Jan ; Kalinowska-Tluscik, Justyna ; Golik, Przemyslaw ; Czub, Miroslawa , et al.
Abstract: Here, we report the fragment-based drug discovery of potent and selective fragments that disrupt the Spire2-FMN2 but not the Spire1-FMN2 interaction. Hit fragments were identified in a differential scanning fluorimetry-based screen of an inhouse library of 755 compounds and subsequently validated in multiple orthogonal biophys. assays, including fluorescence polarization, microscale thermophoresis, and 1H-15N HSQC NMR. Extensive structure-activity relationships combined with mol. docking followed by chem. optimization led to the discovery of compound 13, which exhibits micromolar potency and high ligand efficiency (LE = 0.38). Therefore, this fragment represents a validated starting point for the future development of selective chem. probes targeting the Spire2-FMN2 interaction.
Show More >
Purchased from AmBeed: 63010-72-0 ; 391-82-2 ; 188111-79-7 ; 23432-40-8 ; 75090-52-7 ; 178984-56-0 ; 57260-73-8 ; 21617-12-9 ; 611-35-8 ; 68500-37-8 ; 346-55-4 ; 181950-57-2 ; 216854-23-8 ; 86-98-6 ; 309956-78-3 ; 5407-57-8 ; 625471-18-3 ; 63136-61-8 ; 82121-05-9 ; 259731-83-4 ; 82121-08-2 ; 1557337-03-7 ; 41460-18-8 ; 766544-91-6 ; 256923-25-8 ; 91066-18-1
Show More >
CAS No. : | 188111-79-7 |
Formula : | C10H20N2O2 |
M.W : | 200.28 |
SMILES Code : | C(=O)(OC(C)(C)C)N1CCC[C@H](C1)N |
MDL No. : | MFCD03094717 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H302-H315-H319-H335 |
Precautionary Statements: | P261-P305+P351+P338 |
Num. heavy atoms | 14 |
Num. arom. heavy atoms | 0 |
Fraction Csp3 | 0.9 |
Num. rotatable bonds | 3 |
Num. H-bond acceptors | 3.0 |
Num. H-bond donors | 1.0 |
Molar Refractivity | 59.3 |
TPSA ? Topological Polar Surface Area: Calculated from |
55.56 Ų |
Log Po/w (iLOGP)? iLOGP: in-house physics-based method implemented from |
2.43 |
Log Po/w (XLOGP3)? XLOGP3: Atomistic and knowledge-based method calculated by |
0.73 |
Log Po/w (WLOGP)? WLOGP: Atomistic method implemented from |
0.96 |
Log Po/w (MLOGP)? MLOGP: Topological method implemented from |
0.86 |
Log Po/w (SILICOS-IT)? SILICOS-IT: Hybrid fragmental/topological method calculated by |
0.32 |
Consensus Log Po/w? Consensus Log Po/w: Average of all five predictions |
1.06 |
Log S (ESOL):? ESOL: Topological method implemented from |
-1.34 |
Solubility | 9.08 mg/ml ; 0.0453 mol/l |
Class? Solubility class: Log S scale |
Very soluble |
Log S (Ali)? Ali: Topological method implemented from |
-1.48 |
Solubility | 6.7 mg/ml ; 0.0335 mol/l |
Class? Solubility class: Log S scale |
Very soluble |
Log S (SILICOS-IT)? SILICOS-IT: Fragmental method calculated by |
-0.92 |
Solubility | 24.1 mg/ml ; 0.12 mol/l |
Class? Solubility class: Log S scale |
Soluble |
GI absorption? Gatrointestinal absorption: according to the white of the BOILED-Egg |
High |
BBB permeant? BBB permeation: according to the yolk of the BOILED-Egg |
Yes |
P-gp substrate? P-glycoprotein substrate: SVM model built on 1033 molecules (training set) |
No |
CYP1A2 inhibitor? Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set) |
No |
CYP2C19 inhibitor? Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set) |
No |
CYP2C9 inhibitor? Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set) |
No |
CYP2D6 inhibitor? Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set) |
No |
CYP3A4 inhibitor? Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set) |
No |
Log Kp (skin permeation)? Skin permeation: QSPR model implemented from |
-7.0 cm/s |
Lipinski? Lipinski (Pfizer) filter: implemented from |
0.0 |
Ghose? Ghose filter: implemented from |
None |
Veber? Veber (GSK) filter: implemented from |
0.0 |
Egan? Egan (Pharmacia) filter: implemented from |
0.0 |
Muegge? Muegge (Bayer) filter: implemented from |
0.0 |
Bioavailability Score? Abbott Bioavailability Score: Probability of F > 10% in rat |
0.55 |
PAINS? Pan Assay Interference Structures: implemented from |
0.0 alert |
Brenk? Structural Alert: implemented from |
0.0 alert: heavy_metal |
Leadlikeness? Leadlikeness: implemented from |
No; 1 violation:MW<1.0 |
Synthetic accessibility? Synthetic accessibility score: from 1 (very easy) to 10 (very difficult) |
2.63 |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
82% | With benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate; N-ethyl-N,N-diisopropylamine; In N,N-dimethyl-formamide; at 20℃; for 20h; | A.2.4 Synthesis of (R)-3-[(benzofuran-4-carbonyl)-amino]-piperidine-l- carboxylic acid tert-buty ester; A mixture of (R)-3-amino-l-N-Boc-piperidine (1 g), <strong>[166599-84-4]benzofuran-4-carboxylic acid</strong> (809 mg), PyBOP (2.6g), DIEA (1.96 mL) in dry DMF (10 mL) was stirred at RT under nitrogen for 20 h. The reaction mixture was diluted with EA, washed with water. The aqueous phase was extracted twice with EA, the combined organic extracts were washed with brine, dried (MgSO4), filtered and concentrated to yield a crude light brown oil. FC (EA/ n-heptane: 1/1 to EA) gave 1.41 g (82%) of the title compound as an oil. LC-MS: tR = 0.93 min; [M+H]+ = 345. |
82% | With benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate; N-ethyl-N,N-diisopropylamine; In N,N-dimethyl-formamide; at 20℃; for 20h; | A mixture of (R)-3-amino-1-N-Boc-piperidine (1 g), <strong>[166599-84-4]benzofuran-4-carboxylic acid</strong> (809 mg), PyBOP (2.6 g), DIEA (1.96 mL) in dry DMF (10 mL) was stirred at RT under nitrogen for 20 h. The reaction mixture was diluted with EA, washed with water. The aqueous phase was extracted twice with EA, the combined organic extracts were washed with brine, dried (MgSO4), filtered and concentrated to yield a crude light brown oil. FC (EA/n-heptane: 1/1 to EA) gave 1.41 g (82%) of the title compound as an oil.LC-MS: tR=0.93 min; [M+H]+=345. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
78% | With diisopropylamine; In dichloromethane; at 0 - 20℃; for 1h; | To a mixture of compound 18-1-1 (1 g, 5 mmol) in DCM (10 mL) was added DIPA (1.29 g, 10 mmol) and compound 18-1 (1.13 g, 5 mmol) at 0 C., and the reaction solution was stirred at r.t. for 1 h, followed by evaporation. The solvent was removed and the residue was purified by column chromatography to give compound 18-2 (1 g, Yield 78%). 1H NMR (400 MHz, CDCl3): delta ppm 1.39 (brs, 9H), 1.50-1.61 (m, 1H), 1.62-1.73 (m, 1H), 1.73-1.82 (m, 1H), 1.82-1.93 (m, 1H), 3.24-3.35 (m, 1H), 3.42-3.53 (m, 2H), 3.53-3.62 (m, 1H), 4.11 (d, J=2.65 Hz, 1H), 5.69 (m, 1H), 8.234-8.230 (m, 1H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
81% | With tris-(dibenzylideneacetone)dipalladium(0); sodium t-butanolate; DavePhos; at 100℃; for 16h;Inert atmosphere; Sealed tube; | To a mixture of tris(dibenzylideneacetone)dipalladium(0) (CAS: 51364-51-3; 52 mg,0.057 nnno 1), 2-dicyclohexylphosphino-2 ?-(N,N-dimethylamino)biphenyl (CAS:213697-53-1; 41 mg, 0.104 mmol) and sodium tert-butoxide (154 mg, 1.6 mmol) in1,4-dioxane (5 mL) at rt and under N2 atmosphere, (R)-(-)-3-amino-1-Boc-piperidine(CAS: 188111-79-7; 0.23 mL, 1.2 mmol) and <strong>[3512-75-2]4-chloro-2,6-dimethylpyridine</strong> (0.127mL, 1 mmol) were added. The mixture was heated at 100 °C for 16 h in a sealed tube.Brine and DCM were added and the organic layer was separated, dried over MgSO4,filtered and evaporated under vacuum. The residue thus obtained was purified by flash column chromatography (Si02 amino functionalized; EtOAc in heptane, 0/100 to 100/0) and the desired fractions were concentrated in vacuo affording intermediate 16 as a yellow oil (248 mg, 81percent yield). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With tris-(dibenzylideneacetone)dipalladium(0); 2,2'-bis-(diphenylphosphino)-1,1'-binaphthyl; sodium t-butanolate; In toluene; at 100℃; for 12h;Inert atmosphere; | 10524] WX042-1 (50.00 mg, 240.33 tmol, 1.00 eq), WXBB-3-1 (52.95 mg, 264.36 tmol, 1.10 eq), Pd2(dba)3 (22.01 mg, 24.03 tmol, 0.10 eq), BINAP (29.93 mg, 48.07 tmol, 0.20 eq) and t-BuONa (46.19 mg, 480.65 tmol, 2.00 eq) were added in the reaction flask, then anhydrous methylbenzene (10.00 mE) was added to the reaction flask. Under the nitrogen condition, the reaction liquid was stirred at 1000 C. for 12 h. Afier reaction, the reaction liquid was naturally cooled to room temperature, and filtered. The filtered cake was washed with ethyl acetate (20 mE). The filtrate was combined, concentrated under vacuum to obtain the crude. The crude was diluted with 20 mE of ethyl acetate and 20 mE of water. The pH of aqueous phase was adjusted with (2M) hydrochloric acid aqueous solution to 12. The mix- tare was layered, and then the aqueous phase was collected. The pH of aqueous phase was adjusted with solid sodium bicarbonate to 8, and ethyl acetate (20 mL*3) was added for extraction. The organic phase was combined, washed with saturated sodium chloride solution (10 mE), dried with anhydrous sodium sulfate, and filtered. The filtrate was concentrated under vacuum to obtain WX042-2. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With tris-(dibenzylideneacetone)dipalladium(0); 2,2'-bis-(diphenylphosphino)-1,1'-binaphthyl; sodium t-butanolate; In toluene; at 90.0℃; for 18.0h; | 10225] WXO14-1 (500.00 mg, 2.42 mmol, 1.00 eq) and compound WX1313-3-1 (533.51 mg, 2.66 mmol, 1.10 eq) were dissolved in methylbenzene (25 ml). Tris(dibenzylideneacetone)dipalladium (221.76 mg, 242.00 tmol, 0.10 eq), sodium tert-butoxide (349.08 mg,3.63 mmol,1.50 eq) and binaphthyl (I3INAP) (301.37 mg, 484.00 tmol, 0.20 eq) were added. The mixture was reacted at 90 C. for 18 h. Afier reaction, the reaction liquid was filtered through diatomite, the filtrate was washed with ethyl acetate (10 ml), and dried by rotary evaporation under vacuum. Ethyl acetate (50 ml) was added to residue. The resulting mixture was washed with water (10 ml), the organic phase was dried by rotary evaporation under vacuum, and the crude was purified by column chromatography (petroleum ether:ethyl acetate=30:1-10:1) to obtain the compound WXO14-2. ?H NMR (400 MHz, CDC13) oeppm: 7.76 (s, 1H), 7.22 (s, 1H), 4.79 (d, J=4.00 Hz, 1H), 3.98 (br, s, 1H), 3.30 (br, s, 3H),2.09 (s, 3H), 1.87-1.82 (m, 2H), 1.65-1.58 (m, 3H), 1.33 (s, 9H). |
A145731 [184637-48-7]
tert-Butyl 3-aminopiperidine-1-carboxylate
Similarity: 1.00
A308625 [625471-18-3]
(S)-tert-Butyl 3-aminopiperidine-1-carboxylate
Similarity: 1.00
A133845 [480450-36-0]
(3R,4S)-rel-tert-Butyl 3,4-diaminopiperidine-1-carboxylate
Similarity: 0.98
A142349 [1000796-62-2]
tert-Butyl 3-aminopiperidine-1-carboxylate hydrochloride
Similarity: 0.98
A174847 [1263078-12-1]
(R)-tert-Butyl 3-((tert-butoxycarbonyl)amino)piperidine-1-carboxylate
Similarity: 0.98
A145731 [184637-48-7]
tert-Butyl 3-aminopiperidine-1-carboxylate
Similarity: 1.00
A308625 [625471-18-3]
(S)-tert-Butyl 3-aminopiperidine-1-carboxylate
Similarity: 1.00
A133845 [480450-36-0]
(3R,4S)-rel-tert-Butyl 3,4-diaminopiperidine-1-carboxylate
Similarity: 0.98
A142349 [1000796-62-2]
tert-Butyl 3-aminopiperidine-1-carboxylate hydrochloride
Similarity: 0.98
A174847 [1263078-12-1]
(R)-tert-Butyl 3-((tert-butoxycarbonyl)amino)piperidine-1-carboxylate
Similarity: 0.98
A145731 [184637-48-7]
tert-Butyl 3-aminopiperidine-1-carboxylate
Similarity: 1.00
A308625 [625471-18-3]
(S)-tert-Butyl 3-aminopiperidine-1-carboxylate
Similarity: 1.00
A133845 [480450-36-0]
(3R,4S)-rel-tert-Butyl 3,4-diaminopiperidine-1-carboxylate
Similarity: 0.98
A142349 [1000796-62-2]
tert-Butyl 3-aminopiperidine-1-carboxylate hydrochloride
Similarity: 0.98
A174847 [1263078-12-1]
(R)-tert-Butyl 3-((tert-butoxycarbonyl)amino)piperidine-1-carboxylate
Similarity: 0.98